Search Results - "Olbricht, Christoph"

Refine Results
  1. 1
  2. 2

    The Impact of CYP3A422 on Tacrolimus Pharmacokinetics and Outcome in Clinical Practice at a Single Kidney Transplant Center by Abdel-Kahaar, Emaad, Winter, Stefan, Tremmel, Roman, Schaeffeler, Elke, Olbricht, Christoph J., Wieland, Eberhard, Schwab, Matthias, Shipkova, Maria, Jaeger, Simon U.

    Published in Frontiers in genetics (26-09-2019)
    “…Background: Although there is evidence that the CYP3A4*22 variant should be considered in tacrolimus dosing in renal transplantation, its impact beyond…”
    Get full text
    Journal Article
  3. 3

    Why do we need biomarkers in solid organ transplantation by Olbricht, Christoph J.

    Published in Clinica chimica acta (08-09-2012)
    “…Immunosuppressive therapy is administered to all solid organ transplant recipients to help prevent acute rejection and the loss of allograft function. Adequate…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Biomarkers as a Tool for Management of Immunosuppression in Transplant Patients by WIELAND, Eberhard, OLBRICHT, Christoph J, OELLERICH, Michael, SÜSAL, Caner, GURRAGCHAA, Purevtseren, BÖHLER, Torsten, ISRAELI, Moshe, SOMMERER, Claudia, BUDDE, Klemens, HARTMANN, Bertram, SHIPKOVA, Maria

    Published in Therapeutic drug monitoring (01-10-2010)
    “…Therapeutic drug monitoring is a well-established approach in transplantation medicine to guide immunosuppressive therapy. However, it cannot always predict…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Association Between Pharmacodynamic Biomarkers and Clinical Events in the Early Phase After Kidney Transplantation: A Single-Center Pilot Study by WIELAND, Eberhard, SHIPKOVA, Maria, MARTIUS, Yanina, HASCHE, Georg, KLETT, Corinne, BOLLEY, Renate, OLBRICHT, Christoph J

    Published in Therapeutic drug monitoring (01-06-2011)
    “…Strategies based on monitoring pharmacodynamic effects are increasingly evaluated to individualize immunosuppressive therapy. In the present investigation,…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Oxidant stress in hyperlipidemia-induced renal damage by Scheuer, H, Gwinner, W, Hohbach, J, Gröne, E F, Brandes, R P, Malle, E, Olbricht, C J, Walli, A K, Gröne, H J

    “…Hyperlipoproteinemia can aggravate glomerulosclerosis and chronic tubulointerstitial (ti) damage in kidneys without primary immunologic disease. We evaluated…”
    Get more information
    Journal Article
  10. 10

    Antioxidant-oxidant balance in the glomerulus and proximal tubule of the rat kidney by Gwinner, W, Deters-Evers, U, Brandes, R P, Kubat, B, Koch, K M, Pape, M, Olbricht, C J

    Published in The Journal of physiology (01-06-1998)
    “…Antioxidant and oxidative enzymes were examined in renal glomeruli and proximal tubules of healthy young rats (10-12 weeks old), and results were related to…”
    Get full text
    Journal Article
  11. 11

    Angiography for renal artery stenosis: no additional impairment of renal function by angioplasty by Lufft, Volkmar, Hoogestraat-Lufft, Linda, Fels, Lüder M, Egbeyong-Baiyee, Daniel, Olbricht, Christoph J, Galanski, Michael

    Published in European radiology (01-04-2002)
    “…The aim of this study was to compare renal function between patients with renal angiography and patients with renal angiography and angioplasty (AP) for renal…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    CD26/dipeptidyl peptidase IV: A comparative study of healthy persons and kidney transplant recipients before and early after transplantation by Leicht, Simone, Shipkova, Maria, Klett, Corinne, Gert, Helena, Altrock, Eva, Wilhelm, Jens, Bolley, Renate, Wollmeyer, Jochen, Ender, Andrea, Luz, Beate, Olbricht, Christoph, Wieland, Eberhard

    Published in Clinical biochemistry (01-10-2013)
    “…Human CD26 is co-stimulatory for lymphocytes, circulates in a soluble form in blood (sCD26), and has intrinsic dipeptidyl peptidase IV (DPPIV) activity…”
    Get full text
    Journal Article
  15. 15

    Renal hypertrophy in streptozotocin diabetic rats: Role of proteolytic lysosomal enzymes by Olbricht, Christoph J., Geissinger, Beate, Gutjahr, Elisabeth

    Published in Kidney international (01-04-1992)
    “…Renal hypertrophy in streptozotocin diabetic rats: Role of proteolytic lysosomal enzymes. Renal protein mass increases in diabetic renal hypertrophy. Accretion…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Extracorporeal removal of lipids by dextran sulfate cellulose adsorption by Olbricht, C J

    Published in Artificial organs (01-04-1996)
    “…Extracorporeal removal of low-density lipoprotein (LDL) cholesterol by dextran sulfate adsorption is indicated in patients with diet and drug resistant…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses by Olbricht, Christoph, Wanner, Christoph, Eisenhauer, Thomas, Kliem, Volker, Doll, Rainer, Boddaert, Michel, O'Grady, Padraig, Krekler, Michael, Mangold, Bernhard, Christians, Uwe

    Published in Clinical pharmacology and therapeutics (01-09-1997)
    “…Objectives To study pravastatin and lovastatin pharmacokinetic and pharmacodynamic effects and their interactions with cyclosporine (INN, ciclosporin) in…”
    Get full text
    Journal Article
  20. 20

    Automated Measurement of Competencies and Generation of Feedback in Object-Oriented Programming Courses by Krugel, Johannes, Hubwieser, Peter, Goedicke, Michael, Striewe, Michael, Talbot, Mike, Olbricht, Christoph, Schypula, Melanie, Zettler, Simon

    “…To overcome the shortage of computer specialists, there is an increased need for correspondent study and training offers, in particular for learning…”
    Get full text
    Conference Proceeding